I am an 80-year-old female and a 25-year survivor of ovarian cancer. In the past three years, I have also had Merkel cell cancer, breast cancer, and now ...
Sage Therapeutics said Biogen has terminated the companies' license agreement with respect to its SAGE-324 molecule, a investigational drug targeting essential tremor and epilepsy. The move comes ...